CD8+ T lymphocyte-derived chemokines and other HIV-suppressive factors: Mini-review

Journal of Chemotherapy

Volumn 10, Issue 2, 1998, Pages 146-149

  Furci, L ^a   Polo, S ^a   Lusso, P ^a,b  

^a SAN RAFFAELE HOSPITAL   (Italy)

^b San Raffaele Scientific Institute   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CD8 ANTIGEN; CHEMOKINE; CHEMOKINE RECEPTOR; NEUTRALIZING ANTIBODY;

ANTIVIRAL ACTIVITY; CONFERENCE PAPER; HOST RESISTANCE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; IMMUNITY; T LYMPHOCYTE;

EID: 0031919685     PISSN: 1120009X     EISSN: None     Source Type: Journal    
DOI: 10.1179/joc.1998.10.2.146     Document Type: Conference Paper

References (25)

1. Paul WE. Can the immune response control HIV infection? Cell 1995; 82: 177-82.
2. McCune JM. Viral latency in HIV disease. Cell 1995; 82: 183-8.
3. Shearer G, Clerici M. Protective immunity against HIV infection: has nature done the experiment for us? Immunol Today 1996; 17: 21-24.
4. Baltimore D. Lessons from people with nonprogressive HIV infection. N Engl J Med 1995; 332: 259-60.
5. Toth FD, Szabo B, Ujhelyi E, et al. Neutralizing and complement-dependent enhancing antibodies in different stages of HIV infection. AIDS 1991; 5: 263-8.
6. Riviere Y. Virus-specific cytotoxic T lymphocyte responses in patients infected with the human immunodeficiency virus, HIV-1. Cell Mol Biol 1994; 40: 45-8.
7. Walker BD, Chakrabarti S, Moss B, et al. HIV-specific cytotoxic T lymphocytes in seropositive individuals. Nature 1987; 328: 345-8.
8. Langlade-Demoyen P, Ngo-Giang-Huong N, Ferchal F, Oksenhendler E. HIV nef-specific cytotoxic T lymphocytes in non-infected heterosexual contact of HIV-infected patients. J Clin Invest 1994; 93: 1293-7.
9. Harrer E, Harrer T, Buchbinder S, et al. HIV-1-specific cytotoxic T lymphocyte response in healthy, long-term non-progressing seropositive persons. AIDS Res Hum Retroviruses 1994; 10: S77-8.
10. Walker CM, Moody DJ, Stites DP, Levy JA. CD8+ lymphocytes can control HIV infection in vitro by suppressing virus replication. Science 1986; 234: 1563-6.
11. Mackewicz CE, Ortega HW, Levy JA. CD8+ cell anti-HIV activity correlates with the clinical state of the infected individual. J Clin Invest 1991; 87: 1462-6.
12. Cocchi F, DeVico AL, Garzino-Demo A, Arya SK, Gallo RC, Lusso P. Identification of RANTES, MIP-1 alpha, and MIP-1 beta as the major HIV- suppressive factors produced by CD8+ T cells . Science 1995; 270: 1811-5.
13. Feng Y, Broder CC, Kennedy PE, Berger EA. HIV-1 entry cofactor: functional cDNA cloning of a seven-transmembrane, G protein-coupled receptor. Science 1996; 272: 872-7.
14. Lusso P, Gallo R. Chemokines and HIV infection. Curr Op Infect Dis 1997; 10: 12-17
15. Furci L, Scarlatti G, Burastero S, et al. Antigen-driven C-C chemokine-mediated HIV-1 suppression by CD4(+) T cells from exposed uninfected individuals expressing the wildtype CCR- 5 allele. J Exp Med 1997; 186: 455-60.
16. Saha K, Bentsman G, Chess L, Volsky DJ. Endogenous production of beta-chemokines by CD4+, but not CD8+, T-cell clones correlates with the clinical state of human immunodeficiency virus type 1 (HIV-1)-infected individuals and may be responsible for blocking infection with non-syncytium-inducing HIV-1 in vitro. J Virol 1998; 72: 876-81.
17. Liu R, Paxton WA, Choe S, et al. Homozygous defect in HIV-1 coreceptor accounts for resistance of some multiplyexposed individuals to HIV-1 infection. Cell 1996; 86: 367-77.
18. Samson M, Libert F, Doranz BJ, et al. Resistance to HIV-1 infection in caucasian individuals bearing mutant alleles of the CCR-5 chemokine receptor gene. Nature 1996; 382: 722-5.
19. Bleul CC, Farzan M, Choe H, et al. The lymphocyte chemoattractant SDF-1 is a ligand for LESTR/fusin and blocks HIV-1 entry. Nature 1996; 382: 829-33.
20. Oberlin E, Amara A, Bachelerie F, et al. The CXC chemokine SDF-1 is the ligand for LESTR/fusin and prevents infection by T-cell-line-adapted HIV-1. Nature 1996; 382: 833-5.
21. Polo S, Furci L, Tresoldi E, et al. Expression of macrophage derived chemokine (MDC). but not of stromal cell-derived factor-1 (SDF-1) by ex-vivo activated CD8+ T cells from HIV-1 seropositive patients. Submitted for publication 1998.
22. Lacey SF, McDanal CB, Horuk R, Greenberg ML. The CXC chemokine stromal cell-derived factor 1 is not responsible for CD8+ T cell suppression of syncytia-inducing strains of HIV-1. Proc Natl Acad Sci USA 1997; 94: 9842-7.
23. Winkler C, Modi W, Smith MW, et al. Genetic restriction of AIDS pathogenesis by an SDF-1 chemokine gene variant. Science 1998; 279: 389-93.
24. Pal R, Garzino-Demo A, Markham PD, et al. Inhibition of HIV-1 infection by the beta-chemokine MDC. Science 1997; 278: 695-8.
25. Chen CH, Weinhold KJ, Bartlett JA, Bolognesi DP, Greenberg ML. CD8+ T lymphocyte-mediated inhibition of HIV-1 long terminal repeat transcription: a novel antiviral mechanism. AIDS Res Human Retroviruses 1993; 9: 1079-86.